Kenneth Phelps

Title: The Innovations of Kenneth Phelps

Introduction

Kenneth Phelps is an accomplished inventor based in Cincinnati, OH. He has made significant contributions to the field of pharmaceuticals, particularly in the development of topical formulations for treating fungal infections. His innovative approach addresses a critical need in the medical community.

Latest Patents

Kenneth Phelps holds a patent for "Topical formulations of Flucytosine." This invention relates to formulations that demonstrate a clear advantage over existing therapeutic regimens for the treatment and maintenance of fungal infections, especially vulvovaginal candidiasis. The invention provides compositions that effectively treat resistant strains of fungi while posing limited risks of side effects or the development of resistant pathogens. The novel formulations are designed to allow the active drug to act locally while moderating systemic absorption.

Career Highlights

Kenneth Phelps has dedicated his career to advancing pharmaceutical innovations. His work has led to the development of effective treatments that address long-standing medical challenges. He is currently associated with Calla Therapeutics LLC, where he continues to contribute to groundbreaking research and development.

Collaborations

Kenneth has collaborated with notable professionals in his field, including Jaber Qasem and Raymond H Farmen. These partnerships have enhanced the scope and impact of his work, fostering an environment of innovation and discovery.

Conclusion

Kenneth Phelps exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the development of topical formulations of flucytosine, highlight the importance of addressing resistant strains of infections. His work continues to pave the way for more effective treatments in the medical field.